Vascular endothelial growth factor (VEGF) , a specific marker of angiogenesis, is increased in asthmatic airways following allergen challenge Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006
Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Expression of bradykinin B2 receptor (B2R) and vascular endothelial growth factor (VEGF) in asthma and COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia Source: Eur Respir J 2001; 17: 681-687 Year: 2001
Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF) Source: Eur Respir J 2004; 24: Suppl. 48, 553s Year: 2004
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis? Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012
Vascular endothelial growth factor is upregulated in induced sputum of asthmatic patients after antigenic bronchoprovocation Source: Eur Respir J 2003; 22: Suppl. 45, 349s Year: 2003